AAAAAA

   
Results: 1-14 |
Results: 14
IN-VIVO TOXICITY AND PHARMACOKINETIC FEATURES OF B43 (ANTI-CD19)-GENISTEIN IMMUNOCONJUGATE IN NONHUMAN-PRIMATES
Authors: MESSINGER Y YANISHEVSKI Y EK O ZEREN T WAURZYNIAK B GUNTHER R CHELSTROM L CHANDANLANGLIE M SCHNEIDER E MYERS DE EVANS W UCKUN FM
Citation: Y. Messinger et al., IN-VIVO TOXICITY AND PHARMACOKINETIC FEATURES OF B43 (ANTI-CD19)-GENISTEIN IMMUNOCONJUGATE IN NONHUMAN-PRIMATES, Clinical cancer research, 4(1), 1998, pp. 165-170
IN-VIVO TOXICITY AND PHARMACOKINETIC FEATURES OF B43 (ANTI-CD19)-GENISTEIN IMMUNOCONJUGATE IN NONHUMAN-PRIMATES
Authors: MESSINGER Y YANISHEVSKI Y EK O ZEREN T WAURZYNIAK B GUNTHER R CHELSTROM L CHANDANLANGLIE M SCHNEIDER E MYERS DE EVANS W UCKUN FM
Citation: Y. Messinger et al., IN-VIVO TOXICITY AND PHARMACOKINETIC FEATURES OF B43 (ANTI-CD19)-GENISTEIN IMMUNOCONJUGATE IN NONHUMAN-PRIMATES, Clinical cancer research, 4(1), 1998, pp. 165-170
IN-VIVO TOXICITY AND PHARMACOKINETIC FEATURES OF B43(ANTI-CD19)-GENISTEIN IMMUNOCONJUGATE
Authors: EK O YANISHEVSKI Y ZEREN T WAURZYNIAK B GUNTHER R CHELSTROM L CHANDANLANGLIE M SCHNEIDER E MYERS DE EVANS W UCKUN FM
Citation: O. Ek et al., IN-VIVO TOXICITY AND PHARMACOKINETIC FEATURES OF B43(ANTI-CD19)-GENISTEIN IMMUNOCONJUGATE, Leukemia & lymphoma, 30(3-4), 1998, pp. 389-394
LARGE-SCALE MANUFACTURING OF B43(ANTI-CD19)-GENISTEIN FOR CLINICAL-TRIALS IN LEUKEMIA AND LYMPHOMA
Authors: MYERS DE SICHENEDER A CLEMENTSON D DVORAK N VENKATACHALAM T SEV AR CHANDANLANGLIE M UCKUN FM
Citation: De. Myers et al., LARGE-SCALE MANUFACTURING OF B43(ANTI-CD19)-GENISTEIN FOR CLINICAL-TRIALS IN LEUKEMIA AND LYMPHOMA, Leukemia & lymphoma, 29(3-4), 1998, pp. 329
INDUCTION OF APOPTOSIS IN MULTIDRUG-RESISTANT AND RADIATION-RESISTANTACUTE MYELOID-LEUKEMIA CELLS BY A RECOMBINANT FUSION TOXIN DIRECTED AGAINST THE HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR-RECEPTOR
Authors: PERENTESIS JP WADDICK KG BENDEL AE SHAO Y WARMAN BE CHANDANLANGLIE M UCKUN FM
Citation: Jp. Perentesis et al., INDUCTION OF APOPTOSIS IN MULTIDRUG-RESISTANT AND RADIATION-RESISTANTACUTE MYELOID-LEUKEMIA CELLS BY A RECOMBINANT FUSION TOXIN DIRECTED AGAINST THE HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR-RECEPTOR, Clinical cancer research, 3(3), 1997, pp. 347-355
GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR RECEPTOR-TARGETED THERAPY OF CHEMOTHERAPY-RESISTANT AND RADIATION-RESISTANT HUMAN MYELOID LEUKEMIAS
Authors: PERENTESIS JP BENDEL AE SHAO Y WARMAN B DAVIES SM YANG CH CHANDANLANGLIE M WADDICK KG UCKUN FM
Citation: Jp. Perentesis et al., GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR RECEPTOR-TARGETED THERAPY OF CHEMOTHERAPY-RESISTANT AND RADIATION-RESISTANT HUMAN MYELOID LEUKEMIAS, Leukemia & lymphoma, 25(3-4), 1997, pp. 247
DIFFERENTIAL-EFFECTS OF RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR (RHG-CSF) ON THE RADIATION SENSITIVITY OF NORMAL VERSUS LEUKEMIC BONE-MARROW PROGENITOR-CELL POPULATIONS
Authors: WADDICK KG CHANDANLANGLIE M UCKUN FM
Citation: Kg. Waddick et al., DIFFERENTIAL-EFFECTS OF RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR (RHG-CSF) ON THE RADIATION SENSITIVITY OF NORMAL VERSUS LEUKEMIC BONE-MARROW PROGENITOR-CELL POPULATIONS, Leukemia & lymphoma, 25(1-2), 1997, pp. 77-90
IN-VIVO TOXICITY, PHARMACOKINETIC FEATURES AND IMMUNOGENICITY OF B43 (ANTI-CD19)-GENISTEIN IMMUNOCONJUGATE IN MICE AND NONHUMAN-PRIMATES
Authors: MESSINGER Y YANISHEVSKI Y EK O ZEREN T WAURZYNIAK B GUNTHER R CHELSTROM L CHANDANLANGLIE M SCHNEIDER E MYERS DE UCKUN FM
Citation: Y. Messinger et al., IN-VIVO TOXICITY, PHARMACOKINETIC FEATURES AND IMMUNOGENICITY OF B43 (ANTI-CD19)-GENISTEIN IMMUNOCONJUGATE IN MICE AND NONHUMAN-PRIMATES, Blood, 90(10), 1997, pp. 1467-1467
IN-VITRO AND IN-VIVO ANTILEUKEMIC EFFICACY OF CYCLIC-AMP MODULATING AGENTS AGAINST HUMAN LEUKEMIC B-CELL PRECURSORS
Authors: MYERS DE CHANDANLANGLIE M CHELSTROM LM UCKUN FM
Citation: De. Myers et al., IN-VITRO AND IN-VIVO ANTILEUKEMIC EFFICACY OF CYCLIC-AMP MODULATING AGENTS AGAINST HUMAN LEUKEMIC B-CELL PRECURSORS, Leukemia & lymphoma, 22(3-4), 1996, pp. 259-264
IN-VIVO ANTIMYELOID LEUKEMIA ACTIVITY OF A RECOMBINANT FUSION TOXIN TARGETED TO THE HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR-RECEPTOR
Authors: PERENTESIS JP GUNTHER R WAURZYNIAK B CHELSTROM LM BENDEL AE DAVIES SM SHAO Y WARMAN B CHANDANLANGLIE M WADDICK KG YANISHEVSKI Y EVANS WE UCKUN FM
Citation: Jp. Perentesis et al., IN-VIVO ANTIMYELOID LEUKEMIA ACTIVITY OF A RECOMBINANT FUSION TOXIN TARGETED TO THE HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR-RECEPTOR, Blood, 88(10), 1996, pp. 831-831
IN-VITRO AND IN-VIVO ANTILEUKEMIC ACTIVITY OF B43-POKEWEED ANTIVIRAL PROTEIN AGAINST RADIATION-RESISTANT HUMAN B-CELL PRECURSOR LEUKEMIA-CELLS
Authors: WADDICK KG MYERS DE GUNTHER R CHELSTROM LM CHANDANLANGLIE M IRVIN JD TUMER N UCKUN FM
Citation: Kg. Waddick et al., IN-VITRO AND IN-VIVO ANTILEUKEMIC ACTIVITY OF B43-POKEWEED ANTIVIRAL PROTEIN AGAINST RADIATION-RESISTANT HUMAN B-CELL PRECURSOR LEUKEMIA-CELLS, Blood, 86(11), 1995, pp. 4228-4233
APOPTOTIC KILLING OF CHEMOTHERAPY AND RADIATION-RESISTANT HUMAN MYELOID LEUKEMIAS BY A RECOMBINANT FUSION TOXIN TARGETED TO THE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR-RECEPTOR
Authors: PERENTESIS JP BENDEL AE SHAO Y WARMAN B DAVIES SM CHANDANLANGLIE M WADDICK KG UCKUN FM
Citation: Jp. Perentesis et al., APOPTOTIC KILLING OF CHEMOTHERAPY AND RADIATION-RESISTANT HUMAN MYELOID LEUKEMIAS BY A RECOMBINANT FUSION TOXIN TARGETED TO THE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR-RECEPTOR, Blood, 86(10), 1995, pp. 1729-1729
IN-VITRO AND IN-VIVO ACTIVITY OF TOPOTECAN AGAINST HUMAN B-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA CELLS
Authors: UCKUN FM STEWART CF REAMAN G CHELSTROM LM JIN JH CHANDANLANGLIE M WADDICK KG WHITE J EVANS WE
Citation: Fm. Uckun et al., IN-VITRO AND IN-VIVO ACTIVITY OF TOPOTECAN AGAINST HUMAN B-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA CELLS, Blood, 85(10), 1995, pp. 2817-2828
SENSITIVITY OF PRIMARY CLONOGENIC BLASTS FROM ACUTE LYMPHOBLASTIC-LEUKEMIA PATIENTS TO AN ACTIVATED CYCLOPHOSPHAMIDE, VIZ, MAFOSFAMIDE
Authors: UCKUN FM CHANDANLANGLIE M DOCKHAM PA AEPPLI D SLADEK NE
Citation: Fm. Uckun et al., SENSITIVITY OF PRIMARY CLONOGENIC BLASTS FROM ACUTE LYMPHOBLASTIC-LEUKEMIA PATIENTS TO AN ACTIVATED CYCLOPHOSPHAMIDE, VIZ, MAFOSFAMIDE, Leukemia & lymphoma, 13(5-6), 1994, pp. 417-428
Risultati: 1-14 |